PharmaIndivior, 42 AGs Reach $102M Suboxone Antitrust Settlement
The AGs had claimed that Invidior used 'product hopping' to block competition from generics for its opioid treatment drug.
Covid-19End of COVID Emergency Will Usher in Changes Across the US Health System
As the government prepares to reverse some steps taken during the PHE, here's a glimpse at ways patients will be...
PharmaA Technicality Could Keep RSV Shots From Kids in Need
The CDC is now assessing whether nirsevimab would be eligible for the Vaccines for Children program.
Post-AcuteNursing Home Owners Drained Cash During Pandemic While Residents Deteriorated
Some nursing home owners moved money from their facilities through corporate arrangements that are widespread, and legal, in every state.
Covid-19FDA Experts Are Still Puzzled Over Who Should Get Which COVID Shots and When
Panel disagrees with FDA proposal that everyone get at least one shot a year, saying more information is needed.
PharmaWhat Older Americans Need to Know About Taking Paxlovid
Seek treatment with antiviral therapy, which remains effective against new COVID variants.
PharmaBernie Blasts 'Unacceptable Corporate Greed' As Moderna Mulls 4X Price Hike for COVID Vax
Quadrupling the price of COVID-19 vaccine would make it too expensive for millions of Americans, the Vermont Independent says.
Covid-19Medicare Keeps Spending More on COVID-19 Testing. Fraud and Overspending Are Partly Why.
Medicare's COVID-19 testing costs reached over $2 billion in 2022. The growing costs concern some experts, who say financial incentives...
PayerPaxlovid has been free so far. Next year, sticker shock awaits.
The U.S. government has so far purchased 20 million courses of Paxlovid, priced at about $530 each.
Covid-19Researchers Link 266K Avertable Deaths to COVID Vaccination Rates
The U.S. saw 111 deaths per 100,000 population, more than double the COVID mortality rate of other wealthy nations.
Post-AcuteTighter Focus on Nursing Home Infection Control Offers More Effective Patient Safety
Stricter controls 'will help people move more gracefully toward the end of life,' infection control industry leader says.
Covid-19Paxlovid rebound raises questions, but studies have answers
Biden's rebound is far from the first, although they are reportedly "rare."